Genetic testing for RAD51C mutations: in the clinic and community (Q28253197)

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations

21 January 2018

1 reference

Breast-cancer risk in families with mutations in PALB2

21 January 2018

1 reference

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients

21 January 2018

1 reference

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

21 January 2018

1 reference

Mutations in BRIP1 confer high risk of ovarian cancer

21 January 2018

1 reference

Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs

21 January 2018

1 reference

Mutation of the RAD51C gene in a Fanconi anemia-like disorder

21 January 2018

1 reference

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

21 January 2018

1 reference

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes

21 January 2018

1 reference

Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status

21 January 2018

1 reference

Germline RAD51C mutations confer susceptibility to ovarian cancer

21 January 2018

1 reference

RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families

21 January 2018

1 reference

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

21 January 2018

1 reference

RAD51C germline mutations in breast and ovarian cancer patients

21 January 2018

1 reference

RAD51C germline mutations in breast and ovarian cancer cases from high-risk families

21 January 2018

1 reference

Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing.

21 January 2018

1 reference

Germline mutations in RAD51C in Jewish high cancer risk families

21 January 2018

1 reference

Mutation screening of RAD51C in high-risk breast and ovarian cancer families

21 January 2018

1 reference

BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer

21 January 2018

1 reference

Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer

21 January 2018

1 reference

BRCA1 and BRCA2: 1994 and beyond

21 January 2018

1 reference

Mutation screening of RAD51C in male breast cancer patients.

21 January 2018

1 reference

RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC).

21 January 2018

1 reference

A general framework for estimating the relative pathogenicity of human genetic variants

21 January 2018

1 reference

Genetic testing by cancer site: ovary

21 January 2018

1 reference

Preventing ovarian cancer through genetic testing: a population-based study

21 January 2018

1 reference

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls

21 January 2018

1 reference

Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system

21 January 2018

1 reference

The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer

21 January 2018

1 reference

Effect of Screening on Ovarian Cancer Mortality

21 January 2018

1 reference

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study

21 January 2018

1 reference

RAD51C is a susceptibility gene for ovarian cancer

21 January 2018

1 reference

Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CGE.12548

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

25470109

1 reference

Consolidated OpenCitations Corpus – April 2017